The Effect of Positive End Expiratory Pressure on Central Venous Pressure Among Patients With Different Lung Compliance

Sponsor
Jingyuan,Xu (Other)
Overall Status
Unknown status
CT.gov ID
NCT03341572
Collaborator
(none)
30
1
2
1.5
19.4

Study Details

Study Description

Brief Summary

To observe the effect of PEEP on CVP among patients with different respiratory compliance

Condition or Disease Intervention/Treatment Phase
  • Other: 5,10 and 15cmH2O positive end expiratory pressure
N/A

Detailed Description

30 patients with mechanical ventilation and inserted central venous line will be entered. After gathering demographic data, patients undergone 5,10 and 15cmH2O PEEPs and the respective CVPs of the mentioned points will be recorded. According to the change of CVP, the patients will be divided into high response group and low response group, then comparing the lung compliance and thorax elastic resistance differences between the two groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Positive End Expiratory Pressure on Central Venous Pressure Among Patients With Different Lung Compliance
Anticipated Study Start Date :
Nov 13, 2017
Anticipated Primary Completion Date :
Dec 30, 2017
Anticipated Study Completion Date :
Dec 30, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: high response group

patients undergo 5,10 and 15cmH2O positive end expiratory pressure ,the change of central venous pressure is more than 2.5cmH2O

Other: 5,10 and 15cmH2O positive end expiratory pressure
every patients undergo 5,10 and 15cmH2O positive end expiratory pressure,and observe the central venous pressure of the mentioned points

Placebo Comparator: low response group

the change of CVP is less than 2.5cmH2O

Other: 5,10 and 15cmH2O positive end expiratory pressure
every patients undergo 5,10 and 15cmH2O positive end expiratory pressure,and observe the central venous pressure of the mentioned points

Outcome Measures

Primary Outcome Measures

  1. CVP [half an hour]

    Measure the central venous pressure of the three level PEEPs of 5,10 and 15cmH2O.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients with mechanical ventilation and inserted central venous line
Exclusion Criteria:
  1. The age is less than 18 years old or more than 80 years old;

  2. Pregnant and lying-in woman;

  3. Patients undergoing fluid resuscitation and the speed is more than 200ml/h;

  4. Patients with norepinephrine dose are greater than 15 micro per minute;

  5. Patients with pericarditis、pulmonary heart disease、right heart failure、atrial fibrillation;

  6. Patients with COPD(endogenous PEEP is more than 2cmH2O)、tension pneumonthorax、acute episode asthma

Contacts and Locations

Locations

Site City State Country Postal Code
1 Zhongda Hospital Nanjing Jiangsu China 210000

Sponsors and Collaborators

  • Jingyuan,Xu

Investigators

  • Study Chair: yi yang, doctor, Zhongda Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jingyuan,Xu, Attending doctor, Southeast University, China
ClinicalTrials.gov Identifier:
NCT03341572
Other Study ID Numbers:
  • 2017ZDSYLL094-P01
First Posted:
Nov 14, 2017
Last Update Posted:
Nov 14, 2017
Last Verified:
Nov 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 14, 2017